Back to search

Institutes outside Greece

Evaluation of multipotent adult progenitor cells as a candidate therapy for multiple sclerosis

Abstract

dc:description

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by neuroinflammation, demyelination, and progressive neurological decline. Current therapies mainly target immune modulation but fail to provide neuroprotection or promote repair. In this thesis, the therapeutic potential of multipotent adult progenitor cells (MAPC), a stem cell population with superior expansion capacity compared to mesenchymal stem cells, was evaluated in the context of MS. Using in vitro models, rat-derived MAPC (rMAPC) were shown to suppress autoreactive T-cell proliferation, inhibit macrophage activation, and secrete immunomodulatory mediators such as nitric oxide and prostaglandin E2. These effects were further enhanced when MAPC were exposed to pro-inflammatory cytokines, demonstrating that neuroinflammatory signals can boost their immunomodulatory and neuroprotective functions. MAPC also displayed chemokine-driven migratory properties, enabling them to home to inflamed sites, and promoted the survival of oligodendrocytes under oxidative stress. In vivo experiments in experimental autoimmune encephalomyelitis (EAE) revealed that human MAPC (hMAPC), but not rMAPC, ameliorated disease symptoms, particularly in relapsing-remitting models. The beneficial effects were associated with reduced peripheral T-cell activation and downregulation of pro-inflammatory mediators in the central nervous system. Importantly, MAPC did not exacerbate disease, even under inflammatory conditions, supporting their low immunogenic profile. Collectively, these findings identify MAPC as promising candidates for cell-based therapy in MS, highlighting their capacity to adapt to the host microenvironment and exert both immunomodulatory and neuroprotective effects. This work further underscores the potential of MAPC for translation into future clinical applications in neuroinflammatory diseases.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ravanidis, Stylianos
  • Ραβανίδης, Στυλιανός

Subjects

dc:subject × 26

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59819

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ravanidis, Stylianos; Ραβανίδης, Στυλιανός. Evaluation of multipotent adult progenitor cells as a candidate therapy for multiple sclerosis. Institutes outside Greece, 2016. http://hdl.handle.net/10442/hedi/59819